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PUK-8, a Superoxide Dismutase and Catalase
imetic, Reduces Cardiac Oxidative Stress
nd Ameliorates Pressure Overload-Induced
eart Failure in the Harlequin Mouse Mutant
anessa P. M. van Empel, MD,* Anne T. Bertrand, PHD,* Ralph J. van Oort, MSC,*
oel van der Nagel, BS,* Markus Engelen, MD,† Harold V. van Rijen, PHD,†
ieter A. Doevendans, MD, PHD,‡ Harry J. Crijns, MD, PHD,§ Susan L. Ackerman, PHD,
im Sluiter, PHD,¶ Leon J. De Windt, PHD*
trecht, Maastricht, and Rotterdam, the Netherlands; and Bar Harbor, Maine
OBJECTIVES The purpose of this study was to identify apoptosis-inducing factor (AIF) as a cardiac
mitochondrial antioxidant and assess the efficacy of EUK-8, a salen-manganese catalytic free
radical scavenger, to protect the AIF-deficient myocardium against pressure overload.
BACKGROUND Oxidative stress has been postulated to provoke cell death and pathologic remodeling in heart
failure. We recently characterized the apoptosis-inducing factor-deficient harlequin (Hq)
mouse mutant to display excessive pressure overload-induced oxidative stress, cell death,
accelerated progression to heart failure, and a reduced capacity of subsarcolemmal mitochon-
dria to scavenge free radicals, suggesting a role for AIF as a novel mitochondrial antioxidant.
METHODS Oxidative stress-sensitized Hq mutant mice and their wild-type (WT) counterparts were
given low-dose EUK-8 (25 mg/kg/day), an antioxidant with superoxide dismutase, catalase,
and oxyradical scavenging properties, or vehicle for 4 weeks, and subjected to pressure
overload (transverse aortic constriction) for 4 weeks. Myocardial geometry and function was
serially assessed by echocardiography.
RESULTS EUK-8 ameliorated survival in Hq and WT mice subjected to pressure overload. EUK-8 also
improved left ventricular end-systolic dimensions and fractional shortening, prevented
myocardial oxidant stress, attenuated necrotic and apoptotic cell death, and attenuated cardiac
hypertrophy and fibrosis in both mutant and WT mice.
CONCLUSIONS The protection against pressure overload-induced heart failure in Hq mice by EUK-8
substantiates the notion that AIF functions as an important mitochondrial antioxidant in the
heart. Furthermore, because antioxidant treatment protected both the oxidative stress-prone
Hq mouse model and WT mice against pressure overload-induced maladaptive left
ventricular remodeling and cardiac decompensation, it may be useful as a novel therapeutic
tool in the treatment of human heart failure. (J Am Coll Cardiol 2006;48:824–32) © 2006
ublished by Elsevier Inc. doi:10.1016/j.jacc.2006.02.075by the American College of Cardiology Foundation
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cccumulating evidence suggests that oxidative stress trig-
ers cardiac cell death and the pathogenesis of a number of
ardiovascular diseases, such as ischemic heart disease, heart
ailure, and atherosclerosis (1–3). Production of reactive
xygen species (ROS), such as superoxide anions (·O2
)
nd hydrogen peroxide (H2O2), from mitochondrial sources
s enhanced under various pathologic stimuli (3,4). To
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Manuscript received October 17, 2005; revised manuscript received February 1,
006, accepted February 28, 2006.ounteract oxidative stress, mammalian cells are equipped
ith elaborate antioxidant mechanisms, including superox-
de dismutases (SODs) in mitochondria (MnSOD), the
ytosol (CuZn-SOD), plasma membrane, and extracellular
paces (extracellular SOD), catalase and glutathione peroxi-
ases, and other nonenzymatic antioxidants. Antioxidants
xert their cellular protective effects by directly scavenging
OS or their precursors and by attenuating the catalysis of
OS generation via binding to metal ions.
Apoptosis-inducing factor (AIF) is a highly conserved
avoprotein with pyridine nucleotide-disulphide oxi-
oreductase and deoxyribonucleic acid (DNA) binding
omains. The AIF precursor is synthesized in the cytosol
nd imported into mitochondria, where AIF localizes in the
itochondrial intermembrane space. Changes in mitochon-
rial permeability, secondary to loss of the mitochondrial
embrane potential (m), induces translocation of AIF
nto the cytosol and nucleus where it may participate in
hromatinolysis (5,6). We and others have recently unveiled
n additional role for AIF or programmed cell death 8
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August 15, 2006:824–32 Antioxidants Protect AIF-Deficient Heart MusclePdcd8) as a neuronal and cardiac antioxidant, using the
arlequin (Hq) mutant mouse harboring a proviral insertion
n the first intron of the AIF gene resulting in 90%
ecrement in AIF expression in brain and heart (7,8). The
q mice have a decreased ability to clear oxygen radicals
nd display increased sensitivity to necrotic and apoptotic
ell death, resulting in progressive degeneration of cerebellar
nd retinal neurons (7), increased sensitivity of the myocar-
ium to ischemic insults, and accelerated progression to
eart failure upon pressure overload (8).
The variety of phenotypes observed in Hq mice resembles
hose in experimental models with premature-aging syn-
romes: increased oxidative stress, accelerated progression
o heart failure in response to stress, neurodegenerative
hanges, kyphosis, age-related skin changes, growth retar-
ation, and short life span (9). In fact, intrinsic oxidative
tress was demonstrated to increase with age in the heart,
wing both to age-related impairment of transcriptional
esponses to oxidant stress (10), diminished expression of
ntioxidant defense enzymes such as catalase, glutathione
eroxidase, and MnSOD (11), and increased myocardial
xpression of NADPH oxidases (12) and to age-dependent
ardiac mitochondrial dysfunction (13). Moreover, endog-
nous cardiac AIF protein levels were found to decrease
pon pressure overload and in a genetic model of severe
eart failure (8), mimicking the decrease of other antioxi-
ant enzymes in heart failure (14). These age-related effects
ay contribute to the higher incidence of cardiovascular
isorders, such as heart failure, in the aged population. As
uch, the Hq mouse may serve as a relevant model to study
remature aging-related cardiovascular disorders due to
ecreased antioxidant ability (8).
Accordingly, the aims of the present study were to
stablish the causality of antioxidant defects in the Hq
ouse model by chronic treatment of pressure-overloaded
q mice with EUK-8, an antioxidant with powerful super-
xide dismutase (SOD), catalase, and oxyradical scavenging
roperties. By administering pressure-overloaded wild-type
WT) counterparts with the same compound, the preclinical
fficacy of this synthetic antioxidant to protect the myocardium
Abbreviations and Acronyms
AIF  apoptosis-inducing factor
DNA  deoxyribonucleic acid
DHE  dihydroethidium
FS  fractional shortening
Hq  harlequin
LVID  left ventricular internal dimension
·O2
  superoxide anion
ROS  reactive oxygen species
SOD  superoxide dismutase
TAC  transverse aortic banding
WT  wild-typegainst the noxious effects of pressure overload was tested. wETHODS
ice. Wild-type male and female mice on a B6CBACa-
w-J/A (B6CBA) background and mice hemizygous or
omozygous for the X-linked Hq mutation (Pdcd8Hq) on
he same background were used. All protocols were per-
ormed according to institutional guidelines and approved
y the local animal care and use committee.
ortic banding. Transverse aortic banding (TAC) or sham
urgery was performed in 2-month-old mice by subjecting
he aorta to a defined 25-gauge constriction between the
rst and second truncus of the aortic arch as described
reviously in detail (8). Doppler echocardiography was used
o calculate the pressure gradient between the proximal and
istal sites of the transverse aortic constriction using the
oppler-estimated Bernoulli equation (15), and only mice
ith a pressure gradient 20 mm Hg were used in this
tudy (8).
ransthoracic echocardiography. Noninvasive echocar-
iographic measurements were performed with a Hewlett-
ackard Sonos 5500 instrument (Hewlett-Packard) using a
5-MHz transducer (15-6L linear probe, Philips Medical
ystems, Eindhoven, the Netherlands) applied parasternally
o the shaved chest wall of mice anesthetized with isoflurane
s previously described (16). In M-mode, the following
arameters were obtained: end-diastolic left ventricular inter-
al diameter (LVIDd), end-systolic left ventricular internal
iameter (LVIDs), and posterior wall and interventricular
eptum wall thickness. Fractional shortening (FS) was calcu-
ated as: ([LVIDd  LVIDs]/LVIDd)  100. Animals were
ubjected to serial weekly echocardiographic analyses after
ham operation or aortic banding for the duration of the
tudy (4 weeks).
ntioxidant treatment. The mice were randomized to
reatment with either EUK-8 (intraperitoneal injections, 3
imes a week, 25 mg/kg/day; Calbiochem EMD Bio-
ciences, Darmstadt, Germany) or an equal volume of
ehicle (phosphate-buffered saline) for the duration of the
tudy.
mmunolabeling and histologic analysis. Heart tissue was
xed in 3.7% formaldehyde and embedded in paraffin, and
ectioned at 6-m thickness for visualization. Sections were
tained with hematoxylin and eosin (H&E) or Sirius red or
ncubated with antibodies against cleaved caspase-3 (1:
000; Cell Signaling, Danvers, Massachusetts), cleaved
ARP (1:200; Cell Signaling), or 8-OHdG (7.5 g/l;
xis International Inc., Portland, Oregon). Envision kit
Dako Cytomation, Glostrup, Denmark) was used as a
econdary reagent. Stainings were developed using DAB
brown precipitate), and slides counterstained with hema-
oxylin and visualized using a Nikon Eclipse E600 micro-
cope (Nikon, Melville, New York).
n situ detection of reactive oxygen species. Reactive
xygen species production was determined using the fluo-
escent dye dihydroethidium (DHE). Cryosections (10 m)
ere incubated with 5 mol/l DHE at 37°C for 30 min.
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Antioxidants Protect AIF-Deficient Heart Muscle August 15, 2006:824–32mages were captured on a Zeiss Axiovert 135M micro-
cope (Carl Zeiss MicroImaging, Thornwood, New York)
nd pixel intensity of the nuclei was measured using
POT-advanced software.
tatistical analysis. The results are presented as mean 
EM. Statistical analyses were performed by using
NSTAT 3.0 software (GraphPad, San Diego, California)
nd Student t test or analysis of variance followed by Tukey
ost-test when appropriate. Kaplan-Meier survival curves
ere compared between groups with the use of log rank
ests. Statistical significance was accepted at a p value
f 	0.05.
ESULTS
UK-8 prevents myocardial oxidant damage provoked by
iomechanical stress. Biomechanical stress activates sig-
aling cascades including oxidative stress (17), predisposes
ardiac muscle to late-onset apoptosis (8,18–20), and pro-
okes progressive left ventricular remodeling and heart
ailure (18,19). First, we confirmed whether our TAC
rocedure provoked myocardial oxidative stress and if our
UK-8 treatment regimen could diminish this effect. The
xidative fluorescent dye DHE was used to evaluate the
roduction of superoxide. Dihydroethidium is freely perme-
ble to cells and in the presence of superoxide anions
xidizes to a fluorescent product that is intercalated into the
NA. Fluorescent product is therefore a marker of intra-
ellular superoxide anion generation. All sham-operated
roups showed low levels of superoxide. In response to
ressure overload, however, both WT and Hq mice dem-
nstrated an increased amount of superoxide. This increase
as about 20% higher in Hq mice compared with their WT
ounterparts (Fig. 1A). EUK-8 treated TAC animals, of
oth genotypes, displayed decreased levels of oxidative
tress, to levels similar to sham-operated animals. To
valuate a downstream marker for oxidative stress-related
amage, we stained the myocardium of all genotypes for
-OHdG, a marker for free radical DNA damage. Un-
reated sham-operated animals showed low amounts of
-OHdG–positive nuclei. Aortic banding elevated oxidative
amage in both groups, with Hq-TAC animals displaying
ore damage than their WT-TAC counterparts (Fig. 1B).
arkedly reduced levels of oxidative DNA damage were
vident in EUK-8–treated animals in all experimental
roups. Conclusively, these data directly demonstrate that
q mice, like their WT counterparts, at baseline have no
igns of oxidative stress but display significantly more
roduction of ROS and oxidative stress-induced damage
fter pressure overload than WT mice. Moreover, these data
lso indicate that TAC provokes oxidative stress and dam-
ges crucial structures in the heart and that treatment with
UK-8 effectively counters oxidative damage in pressure-
verloaded animals of all experimental groups. iUK-8 improves survival following biomechanical
tress. Survival rates were evaluated of WT and Hq mice
ubjected to sham operation or pressure overload, treated
ith EUK-8 or vehicle. Survival of the sham-operated mice
n all experimental groups was 100% after 28 days of TAC.
urvival of WT-TAC mice amounted to 68% at 4 weeks,
nd this was improved by the EUK-8 regimen, to 82% (Fig.
). More dramatic differences in survival were evident in the
q experimental groups: Survival of Hq-TAC mice at 28
ays was 38% for the vehicle group and 69% for the
UK-8–treated group (Fig. 2). Overall, these observations
igure 1. (A) Dihydroethidium (DHE) was used to visualize and quantify
he production of superoxide in situ. Wild-type (WT) and harlequin (Hq)
earts demonstrated a significantly higher level of superoxide production
fter aortic banding; this increase was attenuated by administration of
ntioxidant EUK-8. (B) Left ventricular myocardial sections were sub-
ected to immunostaining with 8-OHdG, a marker of oxidative DNA
amage, which was increased in nontreated mice after aortic banding;
owever, EUK-8–treated mice had similar levels of 8-OHdG staining as
ham-operated mice.n post-TAC survival correlate well with the blunted dete-
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August 15, 2006:824–32 Antioxidants Protect AIF-Deficient Heart Muscleioration of cardiac function and geometry in vehicle-treated
T-TAC and Hq-TAC mice compared with WT-TAC
nd Hq-TAC mice treated with EUK-8.
UK-8 prevents functional and geometrical deteriora-
ion in response to pressure overload. Cardiac geometry
nd function was assessed noninvasively by serial echocar-
iography at weekly intervals up to 28 days after TAC (Fig.
A). After 7 days of pressure overload, WT mice demon-
trated no deterioration in cardiac function (FS: sham
5.2  0.9%, 7 days after TAC 55.3  1.0%) (Table 1,
igs. 3A and 3B), whereas Hq mice already demonstrated a
ignificant decline in cardiac function (8), indicated by a
ecrease of 14.7% in FS (sham 52.9  0.7%, 7 days after
AC 45.1  0.9%; p 	 0.05) (Table 1, Figs. 3A and 3B).
t 28 days of pressure overload, WT mice demonstrated a
ignificant decline in FS (sham 55.2  0.9%, 7 days after
AC 55.3  1.0%, 28 days after TAC 43.3  0.9%; p 	
.05 [TAC vs. sham]) (Figs. 3A and 3B). The Hq mice
howed a more pronounced deterioration in cardiac function
n time after pressure overload, as demonstrated by a
rogressive decline in FS (28 days after TAC 31.4  1.0%;
	 0.05 [TAC vs. sham]) (Figs. 3A and 3B), and
ncreasing LVIDs (sham 1.62  0.09 mm, 7 days after
AC 1.63 0.08 mm, 28 days after TAC 2.10 0.09 mm;
	 0.05 [TAC vs. sham]) (Table 1).
Administration of EUK-8 for 28 days provoked no
hange in cardiac function or geometry in either sham-
perated experimental group. In contrast, EUK-8 signifi-
antly improved FS after pressure overload in WT-TAC
ice compared with the corresponding vehicle-treated
roup (WT-TAC  EUK-8: 51.2  1.1%; Hq-TAC 
UK-8: 55.2  1.8%; p 	 0.05 [treated vs. nontreated])
Fig. 3B). Similarly, EUK-8 attenuated the increase in left
entricular (LV) internal diameters in both WT and Hq
ice subjected to biomechanical stress.
After 28 days of pressure overload, both WT and Hq
ice demonstrated a dramatic increase in heart weight
ompared to sham-operated mice, as shown by heart weight
igure 2. Kaplan-Meier survival curve demonstrates increased post-transver
ith wild-type (WT), which was attenuated by EUK-8 treatment.HW) to tibia length (TL) or to body weight (BW) mHW/TL, HW/BW) ratio (Fig. 3C). This increase was
ore pronounced in Hq mice compared to WT. Treatment
ith the antioxidant EUK-8 attenuated the increase in
hese ratios for both genotypes. These data indicate that
UK-8 administration attenuates pressure overload-
nduced functional and geometrical deterioration.
ffect of EUK-8 on cell death and fibrosis. Because
xidative stress provokes apoptotic cell death, the incidence
f that form of cell death was evaluated using immunohis-
ochemical labeling to detect the presence of activated
cleaved) caspase-3 upon sacrifice of all experimental groups
28 days after TAC). A significant increase in apoptosis was
ound after TAC in all experimental groups relative to their
espective sham-operated vehicle-treated groups. The in-
rease in caspase-3–positive cardiac muscle was relatively
ild in WT-TAC mice (3- to 4-fold), whereas Hq-TAC
ice demonstrated a dramatic increase in apoptosis. Treat-
ent with EUK-8 attenuated both the marked increase in
poptotic myocytes in the Hq-TAC as well as in the
T-TAC mice (WT-sham: 0.12  0.01%; WT-sham 
UK-8 0.13  0.01%; Hq-sham: 0.19  0.02%; Hq-sham
EUK-8: 0.15  002%; WT-TAC: 0.38  0.04%;
T-TAC  EUK-8: 0.30  0.04%; Hq-TAC: 0.80 
.07%; Hq-TAC EUK-8: 0.38 0.04%; p	 0.05) (Fig.
A). Immunohistochemical analyses using an antibody to
leaved PARP, a late hallmark of apoptosis, confirmed the
ndings obtained with activated caspase-3, demonstrating
he ability of EUK-8 to markedly reduce apoptotic cell
eath in pressure-overloaded WT and Hq mice (WT-sham:
.30  0.04%; WT-sham  EUK-8: 0.28  0.04%;
q-sham: 0.33  0.07%; Hq-sham  EUK-8: 0.33 
.04%; WT-TAC: 0.88  0.10%; WT-TAC  EUK-8:
.61  0.04%; Hq-TAC: 1.92  0.18%; Hq-TAC 
UK-8: 0.63  1.0%; p 	 0.05) (Fig. 4B).
To further analyze the histologic alterations in the exper-
mental groups, cross-sectional myofiber area and the extent
f fibrosis was assessed. The H&E staining confirmed an
ncrease in cross-sectional myofiber size in response to
tic constriction (TAC) mortality in harlequin (Hq) mutant mice comparedse aorechanical load in both genotypes, although this was more
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Antioxidants Protect AIF-Deficient Heart Muscle August 15, 2006:824–32ronounced in Hq-TAC mice (WT-sham: 179  11 m2;
T-sham  EUK-8: 182  9 m2; Hq-sham: 154  7
m2; Hq-sham  EUK-8: 163  9 m2; WT-TAC:
58  10 m2; WT-TAC  EUK-8: 237  8 m2;
q-TAC: 391  9 m2; Hq-TAC  EUK-8: 242  13
m2; p 	 0.01) (Figs. 5A and 5B). Furthermore, pro-
ounced interstitial fibrosis was evident in Hq-TAC but not
n WT-TAC hearts. EUK-8 treatment resulted in a signif-
cant attenuation of interstitial fibrosis in both genotypes
Figs. 5C and 5D). Collectively, these data demonstrate a
redisposition of AIF-deficient mice to develop LV dys-
unction, dilation, and increased mortality, coupled with
athologic LV remodeling encompassing accentuated oxi-
ative stress, cell death, and fibrosis in response to mechan-
cal load. All these pathologic processes were attenuated by
dministration of the antioxidant EUK-8.
ISCUSSION
IF has a mitochondrial antioxidant function in the
eart. Although AIF has been implicated to play a role in
he execution of the apoptotic pathways (reviewed in Joza et
l. [6]), recent studies indicate an additional role for AIF as
igure 3. (A) Representive M-mode echocardiography images of wild-typ
ollowing sham operation or 7 or 14 days after transverse aortic constriction
imilar in sham-operated mutant and WT mice but was progressively and si
f TAC. (C) The heart weight (HW)/tibial length (TL) ratios increased in
ham-operated groups, although the percentage increase was more pronou
emonstrate a significant increase in HW/TL ratio after TAC comparedfactor conferring protection against peroxide-induced cell meath and neurodegeneration in specific subsets of neurons
7,21) and protecting the myocardium from oxidative stress
nder ischemic or biomechanical stress in response to aortic
anding (8). Although AIF does not appear to physically
ssociate with components of the respiratory complex (22),
t has been proposed that the increased sensitivity to
xidative stress observed in Hq mice results from the
articipation of AIF in mitochondrial respiration by han-
ling of reactive oxygen radicals that are normally released
y the respiratory chain (22). Increased production of ROS
an result from respiratory chain dysfunction and/or de-
reased antioxidant mechanisms. However, we and others
ailed to find alterations in respiratory complex activity in
q hearts (8,22), nor did we observe an increase in
itochondrial number (8) which might compensate for
espiratory deficiencies. In contrast, loss of complex I
ctivity was evident in Hq brain and retina at 10 weeks of
ge (22), which may point to differences between tissues in
ssembly of respiratory complexes or handling free radical
roduction.
Alternatively, our previous findings indicate a deficiency
n the scavenging of exogenous H2O2 in isolated Hq
T) and harlequin (Hq) mice, either treated with vehicle or with EUK-8,
C). (B) Fractional shortening (FS), a measure of systolic contractility, was
antly decreased in Hq mutant mice compared with WT mice after 4 weeks
ted WT and Hq mice after 4 weeks of TAC compared with corresponding
in Hq mutant mice. The WT and Hq mice treated with EUK-8 did not
corresponding sham groups.e (W
(TA
gnific
untreaitochondria (8). Secondly, the data in the present study
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August 15, 2006:824–32 Antioxidants Protect AIF-Deficient Heart Muscleemonstrate that cardiac dysfunction in the AIF-deficient
yocardium could be repaired by exogenous antioxidant
elivery. Thirdly, AIF-negative cells under stress conditions
ere found to deplete nonoxidized glutathione more rapidly
han cells that expressed AIF (23), suggesting that AIF is
ecessary for the maintenance of glutathione levels, at least
nder some conditions. Finally, crystal structures of AIF
eveal 2 functionally distinct regions: a domain required for
NA fragmentation and a domain with homology to
ADH-dependent ferredoxin reductase (24), suggesting
hat AIF may function as a NADH oxidase, accepting
lectrons from NADH and transferring them to molecular
xygen to form the O2
-free radical, which undergoes
ismutation to H2O2 (25). In this light it is of interest to
ote the similarity between the oxidoreductase AIF and the
hioredoxin system, a powerful antioxidant protein-disulfide
xidoreductase system consisting of thioredoxin 1, thiore-
oxin reductase, and NADPH (26). In fact, lowering the
ntioxidant function of the thioredoxin system in the heart
rovokes oxidative stress in the cardiac muscle (27) and
redisposes the heart, as does the Hq mutation, to cardio-
yocyte apoptosis and cardiac decompensation in response
o mechanical load. Our findings are in line with earlier
tudies that indicate that biomechanical stress activates
ignaling cascades including oxidative stress (17), predis-
oses cardiac muscle to late-onset apoptosis (8,18–20), and
rovokes progressive left ventricular remodeling and heart
ailure (18,19). Taken together, the combined observations
trongly suggest that AIF itself, or as part of a yet to be
etermined complex, has direct free radical scavenging
roperties.
ntioxidant treatment in heart failure. Reactive oxygen
pecies have been implicated in a wide range of disorders,
ncluding Alzheimer’s disease, Parkinson’s disease, myocar-
ial arrhythmias, and heart failure, regardless of etiology
able 1. Echocardiographic Characteristics in Wild Type (WT)
ransverse Aortic Constriction (TAC)
Sham
Vehicle EUK-8
WT
(n  7)
Hq
(n  5)
WT
(n  6)
H
(n
W, g 26.9  2.4 23.8  1.3 22.5  1.5 19.9
VS, mm 0.72  0.08 0.83  0.10 0.75  0.04 0.86
VPWth, mm 1.19  0.05 1.15  0.05 0.96  0.05 0.97
DD, mm 3.25  0.12 3.44  0.16 2.93  0.12 3.12
SD, mm 1.46  0.08 1.62  0.09 1.29  0.06 1.40
S, % 55  1 53  1 56.0  1.0 55.2
F, % 90  1 90  1 92  1 90
R, beats/min 479  27 471  31 452  31 457
oPg, mm Hg 4  1 5  1 3  1 3
ata are expressed as mean  SEM. *Indicates p 	 0.05 vs. corresponding sham grou
	 0.05 Hq vs. WT after TAC.
AoPg  aortic pressure gradient; BW  body weight; EDD  end-diastolic diam
hortening calculated as (left ventricular internal diameter in diastole [LVIDd]  LV
left ventricular posterior wall thickness.21,28). Proof of principle in animal models has been
W
pbtained with antioxidants, notably vitamins C and E
29,30), albeit at higher doses than used in clinical trials
31,32). Consequently, many studies have attempted to
meliorate or attenuate the progression of cardiovascular
isease by chronic or acute antioxidant treatment. Such
igure 4. (A) Wild-type (WT) and harlequin (Hq) hearts, subjected to 28
ays of mechanical load, displayed increased myocyte apoptosis as scored by
leaved caspase-3–positive myocytes. The percentage increase in Hq
utants was more pronounced and was attenuated by treatment with
UK-8. (B) The WT and Hq hearts demonstrated increased cleaved
ARP-positive myocytes after transverse aortic constriction (TAC), with
he percentage increase in Hq mutants being more pronounced than in
arlequin (Hq) Mice After Sham Operation and After
TAC
Vehicle EUK-8
WT
(n  7)
Hq
(n  8)
WT
(n  7)
Hq
(n  8)
29.9  0.6 24.2  0.7 28.4  2.5 22.7  1.5
2 1.25  0.03* 1.17  0.06* 0.97  0.04† 0.91  0.05†
6 1.63  0.06* 1.62  0.05* 1.28  0.05*† 1.15  0.05†
0 3.04  0.11 3.05  0.09 3.05  0.11 3.17  0.16
5 1.72  0.05 2.10  0.09*‡ 1.50  0.09 1.55  0.10†
43.4  0.9* 31.4  1.0*‡ 50.8  1.4† 51.2  1.1*†
82  1 68  1 88  1 88  1
494  14 483  18 525  25 486  14
24  5 23  3 20  2 25  3
dicates p 	 0.05 vs. vehicle-treated group with same genotype after TAC. ‡Indicates
F  ejection fraction; ESD  end-systolic diameter; FS  left ventricular fractional
ystole)/LVIDd; HR  heart rate; IVS  intraventricular septal thickness; LVPWthand H
q
 4)
 2.8
 0.0
 0.0
 0.1
 0.0
 1.8
 1
 17
 1
p. †In
eter; E
ID in sT. Treatment with EUK-8 significantly reduced the amount of PARP-
ositive myocytes in Hq-TAC hearts.
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Antioxidants Protect AIF-Deficient Heart Muscle August 15, 2006:824–32igure 5. (A) Representive hematoxylin and eosin (H&E) sections at 400 magnification of wild-type (WT) and harlequin (Hq) hearts, treated with
ehicle or EUK-8, either after sham treatment or 28 days of transverse aortic constriction (TAC). The Hq-TAC mice demonstrated a marked increase in
yocyte fiber diameter compared with other experimental groups; this increase was attenuated by treatment with EUK-8. (B) Quantification of
ross-sectional area of myofibers from indicated groups shows an accentuated myocyte hypertrophy response in Hq-TAC mice. (C, D) Sirius red staining
emonstrates significant fibrosis in Hq mice after TAC, which is diminished by EUK-8 administration.
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August 15, 2006:824–32 Antioxidants Protect AIF-Deficient Heart Muscletudies have yielded at best equivocal or mildly beneficial
esults with regard to slowing disease progression or im-
roving specific indicators (2,31,33,34).
Those studies seem to cast doubt on the oxidative stress
heory of cardiovascular disease, but there are several reasons
o believe that this is not justified. Although vitamin E
ffectively scavenges lipid peroxyl radicals, it has limited
ctivity against other oxidants, such as superoxide, peroxyni-
rite, and hypochlorous acid. The rate constant for the
eaction of vitamin E with O2
 is 5 orders of magnitude
lower than the rate of reaction of O2
 with endogenous
ntioxidant enzymes and molecules such as superoxide
ismutase and nitric oxide (35). Further, oral intake of
itamin E only modestly increases its plasma and tissue
evels, making it unlikely that these vitamins may affect
iologic processes. Finally, many of the oxidative reactions
hat contribute to heart failure occur in the cytoplasm,
ucleus, and interstitial space. Vitamin E is concentrated in
ipid layers and in the low-density lipoprotein particle and is
herefore unlikely to affect these events. Also, vitamin E
ay have adverse pro-oxidant effects, because the toco-
heroxyl radical generated when vitamin E reacts with a
adical can promote lipid peroxidation by attacking polyun-
aturated fatty acids (36). In theory, efficacy should be
mproved by using catalytic antioxidants that can destroy
ultiple toxic mitochondrial ROS without themselves be-
oming inactivated.
The compounds used in this study, synthetic mimetics of
uperoxide dismutase and catalase, are examples of such
gents. At the cellular level, EUK-8 is known to dismutate
2
 to H2O2 and then further catalyze its breakdown to
2O and O2, and it is capable of nitrosative species
reakdown, such as reducing ONOO to NO2
 or oxidiz-
ng NO to NO3
 (37). Our data show that the compound,
dministered at 25 mg/kg, extended the life span of
ressure-overloaded WT and AIF-deficient mice. Our data
re in line with beneficial effects of EUK-8 in protecting
ultured cardiomyocytes against excessive free radical injury
rovoked by H2O2 treatment (8), providing cardioprotec-
ion in aged rats (38), dampening adrenergic hypertrophy
ignaling in cultured cardiomyocytes (39,40), and attenuat-
ng ischemia/reperfusion injury (41) and postischemic
eperfusion arrhythmias (42) in the rat heart.
It has been argued (43) that manganese-salens may
articipate in a much wider range of cellular reactions.
iven their chemical structure, these compounds may also
emove radical species that are produced as a part of normal
etabolic processes and, as such, could act as antimetabo-
ites, slowing down metabolism and indirectly preventing
xidative damage (43). These considerations warrant future
nvestigation of the precise mode of action of manganese-
alens before ascribing its protective properties exclusively to
emoval of superoxide. Despite this cautionary note, the
rotective effect of EUK-8 supplementation in the AIF
ypomorphic mutant is likely more related to removal of
xcess superoxide, because pressure-overloaded Hq heartuscle demonstrates increased oxidative stress which was
educed to baseline levels by EUK-8 supplementation
Fig. 1).
undamental and clinical perspectives. The ramifications
f the present study are several. First, because Hq mutant
ice display numerous aspects of premature-aging syn-
rome, this mouse model may serve as a new and unique
enetic model to study the degenerative processes of cardiac
ging. Second, using a pharmacologic antioxidant approach,
e “corrected” the genetic defect underlying the suscepti-
ility of the Hq mouse heart to cope with injury in the form
f sustained pressure overload, unveiling the precise nature
f function of AIF (free radical scavenging) in cardiac tissue
nd, possibly, in other cell types. Finally, these observations
n AIF hypomorphic mice suggest that the class of synthetic
atalytic “mitoprotective” antioxidants exemplified by
UK-8 can permeate the myocardium, gain access to the
itochondria, and attenuate the mitochondrial damage
ttributable to oxidative stress as well as the secondary
eactions resulting from oxidative stress after pressure over-
oad, including DNA damage, cell death, fibrosis, unfavor-
ble left ventricular remodeling, and mortality. Because
UK-8 also protected pressure-overloaded WT mice, the
resent study provides the first preclinical data suggesting
he potential efficacy of a complete new class of drugs for
eart disease for the general population. Given the ambig-
ous reports of the efficacy of tested antioxidants in heart
ailure, our findings with EUK-8 open the avenue for this
lass of membrane-permeable drug for therapeutic clinical
se in patients.
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